Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Secondary renal tubular dysgenesis in a newborn exposed to angiotensin II receptor antagonist during gestation

  • Gang, Mi Hyeon (Department of Pediatrics, Chungnam National University Hospital, Chungnam National University College of Medicine) ;
  • Lee, Yong Wook (Department of Pediatrics, Chungnam National University Hospital, Chungnam National University College of Medicine) ;
  • Chang, Mea-young (Department of Pediatrics, Chungnam National University Hospital, Chungnam National University College of Medicine)
  • Received : 2020.04.27
  • Accepted : 2020.06.19
  • Published : 2021.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 2012;60:444-50. https://doi.org/10.1161/HYPERTENSIONAHA.112.196352
  2. Prasad N, Gulati S, Jain M, Tewari P. An unusual case of neonatal anuria. Indian Pediatr 2003;40:258-60.
  3. Uematsu M, Sakamoto O, Ohura T, Shimizu N, Satomura K, Tsuchiya S. A further case of renal tubular dysgenesis surviving the neonatal period. Eur J Pediatr 2009;168:207-9. https://doi.org/10.1007/s00431-008-0743-9
  4. Koklu E, Gurgoze M, Akgun H, Ozturk MA, Poyrazoglu MH. Renal tubular dysgenesis with atypical histology and in-utero exposure to naproxen sodium. Ann Trop Paediatr 2006;26:241-5. https://doi.org/10.1179/146532806X120345
  5. Vendemmia M, Garcia-Meric P, Rizzotti A, Boubred F, Lacroze V, Liprandi A, et al. Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists. J Matern Fetal Neonatal Med 2005;18:137-40. https://doi.org/10.1080/14767050500217244
  6. Gubler MC, Antignac C. Renin-angiotensin system in kidney development: renal tubular dysgenesis. Kidney Int 2010;77:400-6. https://doi.org/10.1038/ki.2009.423
  7. Spaggiari E, Heidet L, Grange G, Guimiot F, Dreux S, Delezoide AL, et al. Prognosis and outcome of pregnancies exposed to renin-angiotensin system blockers. Prenat Diagn 2012;32:1071-6. https://doi.org/10.1002/pd.3960
  8. Ra JJ, Eun HS, Lee SM, Park MS, Namgung R, Lee C, et al. A case of neonate with acute renal failure after maternal treatment with angiotensin II receptor blocker. Korean J Perinatol 2012;23:286-91.
  9. Ri S, Shin J, Je BK, Choi BM. Hypocalvaria of newborn infant: intrauterine exposure to an angiotensin receptor blocker. Perinatology 2017;28:103-7. https://doi.org/10.14734/pn.2017.28.3.103

Cited by

  1. Inhibition of the renin-angiotensin system during fetal kidney development vol.64, pp.3, 2021, https://doi.org/10.3345/cep.2020.01228
  2. Multiple drugs : Secondary renal tubular dysgenesis following in utero exposure and lack of efficacy: case report vol.1877, pp.1, 2021, https://doi.org/10.1007/s40278-021-03859-5